Rarer HCV Types Still Need Attention
Genotype 1 most common, but others also appear in U.S.
by
Contributing Writer, MedPage Today
Direct-acting agents (DAAs) have been so effective for genotype 1 that success rates have skyrocketed. Encouragingly, genotype 4 tends to also respond well to these agents. And, work continues on DAAs with newer antiviral agents showing excellent action on non-genotype 1 versions of HCV.....
When compared with other HCV patients, genotype 3 patients are relatively difficult to treat, especially those with cirrhosis. However, studies with sofosbuvir-velpatasvir are "encouraging, with SVR [sustained virologic response] rates of 97% in treatment-naïve patients and 90% in treatment-experienced patients."
Continue reading.....
Recommended Reading
Feb 16, 2017
HCV Genotype 1 No Longer a Treatment Bugbear
by
No comments:
Post a Comment